
Eric Singhi/faculty.mdanderson.org
Jun 28, 2025, 05:37
Eric K. Singhi: BAY88 Has a Name – Sevabertinib
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:
“BAY88 has a name – Sevabertinib
Dr. Xiuning Le excellently reviews updates for the drug. Although small numbers, for treatment-naive patients, ORR ~60%.”
More posts featuring Eric K. Singhi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 18:12
Jul 19, 2025, 17:49
Jul 19, 2025, 17:27
Jul 19, 2025, 17:26
Jul 19, 2025, 16:48
Jul 19, 2025, 16:41
Jul 19, 2025, 16:06